These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 33199969)

  • 1. Synthesis of novel coumarin analogues: Investigation of molecular docking interaction of SARS-CoV-2 proteins with natural and synthetic coumarin analogues and their pharmacokinetics studies.
    Chidambaram S; El-Sheikh MA; Alfarhan AH; Radhakrishnan S; Akbar I
    Saudi J Biol Sci; 2021 Jan; 28(1):1100-1108. PubMed ID: 33199969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico molecular docking: Evaluation of coumarin based derivatives against SARS-CoV-2.
    Chidambaram SK; Ali D; Alarifi S; Radhakrishnan S; Akbar I
    J Infect Public Health; 2020 Nov; 13(11):1671-1677. PubMed ID: 33008777
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Maurya AK; Mishra N
    J Biomol Struct Dyn; 2021 Nov; 39(18):7306-7321. PubMed ID: 32835632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virtual screening, ADMET prediction and dynamics simulation of potential compounds targeting the main protease of SARS-CoV-2.
    Yadav R; Imran M; Dhamija P; Chaurasia DK; Handu S
    J Biomol Struct Dyn; 2021 Oct; 39(17):6617-6632. PubMed ID: 32715956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Silico Evaluation of the Effectivity of Approved Protease Inhibitors against the Main Protease of the Novel SARS-CoV-2 Virus.
    Eleftheriou P; Amanatidou D; Petrou A; Geronikaki A
    Molecules; 2020 May; 25(11):. PubMed ID: 32485894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Potential Inhibitors of 3CL Protease of SARS-CoV-2 From ZINC Database by Molecular Docking-Based Virtual Screening.
    Abdusalam AAA; Murugaiyah V
    Front Mol Biosci; 2020; 7():603037. PubMed ID: 33392261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico studies on stilbenolignan analogues as SARS-CoV-2 Mpro inhibitors.
    Cetin A
    Chem Phys Lett; 2021 May; 771():138563. PubMed ID: 33776065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational screening of dual inhibitors from FDA approved antiviral drugs on SARS-CoV-2 spike protein and the main protease using molecular docking approach.
    Sabarimurugan S; Purushothaman I; Swaminathan R; Dharmarajan A; Warrier S; Kothandan S
    Acta Virol; 2021; 65(2):160-172. PubMed ID: 34130467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-targeted molecular docking, pharmacokinetics, and drug-likeness evaluation of coumarin based compounds targeting proteins involved in development of COVID-19.
    Mun CS; Hui LY; Sing LC; Karunakaran R; Ravichandran V
    Saudi J Biol Sci; 2022 Dec; 29(12):103458. PubMed ID: 36187455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and
    Özdemir M; Köksoy B; Ceyhan D; Sayın K; Erçağ E; Bulut M; Yalçın B
    J Biomol Struct Dyn; 2022 Jul; 40(11):4905-4920. PubMed ID: 33357038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding site analysis of potential protease inhibitors of COVID-19 using AutoDock.
    Mothay D; Ramesh KV
    Virusdisease; 2020 Jun; 31(2):194-199. PubMed ID: 32363219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico drug discovery of major metabolites from spices as SARS-CoV-2 main protease inhibitors.
    Ibrahim MAA; Abdelrahman AHM; Hussien TA; Badr EAA; Mohamed TA; El-Seedi HR; Pare PW; Efferth T; Hegazy MF
    Comput Biol Med; 2020 Nov; 126():104046. PubMed ID: 33065388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virtual screening, ADME/T, and binding free energy analysis of anti-viral, anti-protease, and anti-infectious compounds against NSP10/NSP16 methyltransferase and main protease of SARS CoV-2.
    Maurya SK; Maurya AK; Mishra N; Siddique HR
    J Recept Signal Transduct Res; 2020 Dec; 40(6):605-612. PubMed ID: 32476594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening of plant-based natural compounds as a potential COVID-19 main protease inhibitor: an
    Majumder R; Mandal M
    J Biomol Struct Dyn; 2022 Feb; 40(2):696-711. PubMed ID: 32897138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing.
    Kumar Y; Singh H; Patel CN
    J Infect Public Health; 2020 Sep; 13(9):1210-1223. PubMed ID: 32561274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico identification of potential inhibitors of key SARS-CoV-2 3CL hydrolase (Mpro) via molecular docking, MMGBSA predictive binding energy calculations, and molecular dynamics simulation.
    Choudhary MI; Shaikh M; Tul-Wahab A; Ur-Rahman A
    PLoS One; 2020; 15(7):e0235030. PubMed ID: 32706783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silybin B and Cianidanol Inhibit M
    Srivastava R; Tripathi S; Unni S; Hussain A; Haque S; Dasgupta N; Singh V; Mishra BN
    Curr Pharm Des; 2021; 27(32):3476-3489. PubMed ID: 33302853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virtual screenings of the bioactive constituents of tea, prickly chaff, catechu, lemon, black pepper, and synthetic compounds with the main protease (Mpro) and human angiotensin-converting enzyme 2 (ACE 2) of SARS-CoV-2.
    Emon NU; Alam MM; Akter I; Akhter S; Sneha AA; Irtiza M; Afroj M; Munni A; Chowdhury MH; Hossain S
    Futur J Pharm Sci; 2021; 7(1):121. PubMed ID: 34150913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential of Natural Alkaloids From Jadwar (
    Kumar A; Sharma M; Richardson CD; Kelvin DJ
    Front Mol Biosci; 2022; 9():898874. PubMed ID: 35620478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of the prototypical α-ketoamide inhibitor with the SARS-CoV-2 main protease active site in silico: Molecular dynamic simulations highlight the stability of the ligand-protein complex.
    Liang J; Pitsillou E; Karagiannis C; Darmawan KK; Ng K; Hung A; Karagiannis TC
    Comput Biol Chem; 2020 May; 87():107292. PubMed ID: 32485652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.